In patients with HFpEF and obesity, semaglutide increased weight loss and reduced symptoms and physical limitations at 52 wk

被引：2
|
作者：
Ali, Hyeon-Ju [1 ]
Deswal, Anita [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2023年 / 176卷 / 12期
关键词：
D O I：
10.7326/J23-0101
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Source Citation Kosiborod MN, AbildstrOm SZ, Borlaug BA, et al; STEP-HFpEF Trial Committees and Investigators. Semaglutide in patients with heart failure with preserved ejection fraction and obesity. N Engl J Med. 2023;389:1069-1084. 37622681 Clinical Impact Ratings GIM/FP/GP: Cardiology:
引用
收藏
页码：JC136 / JC136
页数：1
相关论文
共 50 条
  • [1] In HFpEF with obesity, semaglutide improved health status and weight loss at 52 wk, regardless of initial health status
    Lau, Darren
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (05) : JC56 - JC56
  • [2] Semaglutide 2.4 mg/wk for weight loss in patients with severe obesity and with or without a history of bariatric surgery
    Bonnet, Jean-Baptiste
    Tournayre, Sarah
    Anitcheou, Jean
    Faivre, Marion
    Boegner, Catherine
    Jalek, Abdulkader
    Jullien, Dominique
    Attalin, Vincent
    Myzia, Justine
    Marty, Lucile
    Kemba, Youadigue
    Nocca, David
    Sultan, Ariane
    Avignon, Antoine
    OBESITY, 2024, 32 (01) : 50 - 58
  • [3] In overweight or obesity without diabetes, weekly semaglutide vs. daily liraglutide increased weight loss at 68 wk
    Kauffman, Robert P.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (05) : JC56 - JC56
  • [4] Semaglutide provides both weight loss and reduced heart failure symptoms
    Benestad, Haakon B.
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2023, 143 (17)
  • [5] In obesity or overweight without diabetes, orforglipron increased weight loss at 26 wk
    Lau, Darren
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (10) : JC116 - JC116
  • [6] Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity
    Ghusn, Wissam
    De la Rosa, Alan
    Sacoto, Daniel
    Cifuentes, Lizeth
    Campos, Alejandro
    Feris, Fauzi
    Hurtado, Maria Daniela
    Acosta, Andres
    JAMA NETWORK OPEN, 2022, 5 (09) : E2231982
  • [7] Sleep is increased by the development of obesity and reduced by weight loss in mice
    Guan, Z.
    Fang, J.
    Vgontzas, A.
    Bixler, E.
    SLEEP, 2007, 30 : A34 - A34
  • [8] In adults with overweight or obesity, continued weekly semaglutide after a 20-wk run-in improved weight loss
    Lau, Darren
    Padwal, Raj
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (08) : JC88 - JC88
  • [9] Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity
    Desai, Aakash
    Khataniar, Himsikhar
    Hashash, Jana G.
    Farraye, Francis A.
    Regueiro, Miguel
    Kochhar, Gursimran S.
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [10] In adults with obesity and knee OA, adding weekly semaglutide to diet and activity counseling reduced weight and knee pain at 68 wk
    Bell, David S. H.
    ANNALS OF INTERNAL MEDICINE, 2025, 178 (02) : JC20 - JC20
12345